文献速递免疫规划

携带修饰脂质A部分的外膜囊泡增强流感疫苗效力并在小鼠模型中显示降低的内毒素毒性

Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model.
PubMed 文献 · Vaccine · 2016-12-23

研究通过修饰脂多糖脂质A结构制备低内毒素毒性外膜囊泡(fmOMV),并在小鼠流感疫苗模型中评估其鼻内佐剂效果。与天然OMV相比,fmOMV的Toll样受体4刺激活性和内毒素毒性降低;与抗原共免疫显著增强全身抗体和T细胞应答、黏膜IgA水平及肺驻留流感特异性T细胞频率,并提高致死剂量同源或异源流感病毒攻击后的保护率且无不良反应。

要点

  • fmOMV较天然OMV降低Toll样受体4刺激活性和内毒素毒性。
  • 鼻内共注射fmOMV与疫苗抗原显著增强全身抗体、T细胞应答及黏膜IgA水平。
  • fmOMV共免疫小鼠对致死剂量同源或异源流感病毒攻击的保护率显著提高且无不良反应。

核心结论

  • fmOMV作为鼻内疫苗黏膜佐剂具有增强流感疫苗效力的潜力。

研究设计与样本

  • 在小鼠流感疫苗模型中,将修饰脂质A结构制备的低内毒素毒性外膜囊泡(fmOMV)作为鼻内疫苗佐剂进行研究。

主要发现

  • fmOMV较天然OMV exhibit降低的Toll样受体4刺激活性和减弱的内毒素毒性。
  • 鼻内注射疫苗抗原与fmOMV共免疫显著增加全身抗体和T细胞应答、黏膜IgA水平及肺驻留流感特异性T细胞频率。
  • fmOMV共给药后纵隔淋巴结中携带抗原的CD103+树突状细胞数量显著增加。
  • fmOMV共免疫小鼠对致死剂量同源或异源流感病毒攻击的保护率显著提高且无不良反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Influenza is an acute respiratory disease and a major health problem worldwide. Since mucosal immunity plays a critical role in protection against influenza virus infection, mucosal immunization is considered a promising vaccination route. However, except for live-attenuated vaccines, there are no effective killed or recombinant mucosal influenza vaccines to date. Outer membrane vesicles (OMVs) are nano-sized vesicles produced by gram-negative bacteria, and contain various bacterial components capable of stimulating the immune system of the host. We generated an OMV with low endotoxicity (fmOMV) by modifying the structure of the lipid A moiety of lipopolysaccharide and investigated its effect as an intranasal vaccine adjuvant in an influenza vaccine model. In this model, fmOMV exhibited reduced toll-like receptor 4-stimulating activity and attenuated endotoxicity compared to that of native OMV. Intranasal injection of the vaccine antigen with fmOMV significantly increased systemic antibody and T cell responses, mucosal IgA levels, and the frequency of lung-resident influenza-specific T cells. In addition, the number of antigen-bearing CD103+ dendritic cells in the mediastinal lymph nodes was significantly increased after fmOMV co-administration. Notably, the mice co-immunized with fmOMV showed a significantly higher protection rate against challenge with a lethal dose of homologous or heterologous influenza viruses without adverse effects. These results show the potential of fmOMV as an effective mucosal adjuvant for intranasal vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lee TY, Kim CU, Bae EH, et al. Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model. Vaccine. 2016. PMID: 28024958. doi:10.1016/j.vaccine.2016.12.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。